Potassium citrate, a proven Earth-based therapy to minimize calcium-containing renal stone development, is being tested in a double-blind study as a countermeasure to reduce the risk of renal stone formation in crewmembers on the International Space Station. Subjects ingest two potassium citrate or placebo pills with the last meal of the day from L-3 (days prior launch) to R+14 (days after landing). Food, fluid, exercise, and medications are monitored for 48 hours (24 hours prior to and during the 24-hour urine collection period) to assess environmental influences other than microgravity.


    Access

    Check access

    Check availability in my library

    Order at Subito €


    Export, share and cite



    Title :

    Renal stone risk during spaceflight: assessment and countermeasure validation


    Contributors:
    Whitson, P. (author) / Bergh, K. (author) / Maender, C. (author) / Pietrzyk, R. (author) / Jones, J. (author) / Sams, C. (author)


    Publication date :

    2004-01-01


    Size :

    502821 byte





    Type of media :

    Conference paper


    Type of material :

    Electronic Resource


    Language :

    English



    Renal Stone Risk During Spaceflight: Assessment and Countermeasure Validation

    Pietrzyk, Robert A. / Whitson, Peggy A. / Sams, Clarence F. et al. | NTRS | 2009



    Renal stone assessment during spaceflight - Assessment and countermeausure validation

    Whitson, Peggy / Pietrzyk, Robert / Jones, Jeffrey et al. | AIAA | 2001


    AIAA-2001-4901 Renal Stone Risk During Space Flight: Assessment and Countermeasure Validation

    Whitson, P. / Pietrzyk, R. / Jones, J. et al. | British Library Conference Proceedings | 2001